Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review
Babken Asatryan, Angeliki Asimaki, Andrew P. Landstrom, et al.
Circulation (2021) Vol. 144, Iss. 20, pp. 1646-1655
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

2023 ESC Guidelines for the management of cardiomyopathies
Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3503-3626
Open Access | Times Cited: 1038
Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications
Haixia Zhang, Ke Yang, Feng Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 84
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report
Domenico Corrado, Aris Anastasakis, Cristina Basso, et al.
International Journal of Cardiology (2023) Vol. 395, pp. 131447-131447
Open Access | Times Cited: 69
Fir(e)ing the Rhythm
Pietro Enea Lazzerini, Antonio Abbate, Mohamed Boutjdir, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 6, pp. 728-750
Open Access | Times Cited: 48
AAV9:PKP2 improves heart function and survival in a Pkp2-deficient mouse model of arrhythmogenic right ventricular cardiomyopathy
Iris Wu, Aliya Zeng, Amara Greer-Short, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 21
Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy–Associated Putative Pathogenic Gene Variants in UK Biobank Participants
Ravi A. Shah, Babken Asatryan, Ghaith Sharaf Dabbagh, et al.
Circulation (2022) Vol. 146, Iss. 2, pp. 110-124
Open Access | Times Cited: 61
Myocarditis-like Episodes in Patients with Arrhythmogenic Cardiomyopathy: A Systematic Review on the So-Called Hot-Phase of the Disease
Riccardo Bariani, Ilaria Rigato, Alberto Cipriani, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1324-1324
Open Access | Times Cited: 40
Role of genetics in inflammatory cardiomyopathy
Paul J. Scheel, Iside Cartella, Brittney Murray, et al.
International Journal of Cardiology (2024) Vol. 400, pp. 131777-131777
Closed Access | Times Cited: 14
Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy
Mengxia Fu, Xiumeng Hua, Songren Shu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Trends and Disparities Around Cardiovascular Mortality in Sarcoidosis: Does Big Data Have the Answers?
Raheel Ahmed, Rakesh Sharma, C. Anwar A. Chahal
Journal of the American Heart Association (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 11
NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy
Stephen P. Chelko, Vinay Penna, Morgan Engel, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 10
Open Access | Times Cited: 11
Cardiac Sarcoidosis and Inherited Cardiomyopathies: Clinical Masquerade or Overlap?
Sami Fouda, Rebecca Godfrey, Christopher Pavitt, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1609-1609
Open Access | Times Cited: 1
Spatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathy
Cornelis J. Boogerd, Grégory Lacraz, Ábel Vértesy, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 2, pp. 477-491
Open Access | Times Cited: 28
Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench
Giovanni Peretto, Elena Sommariva, Chiara Di Resta, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 646-646
Open Access | Times Cited: 20
Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy
Giovanni Peretto, Michela Casella, Marco Merlo, et al.
JACC. Clinical electrophysiology (2023) Vol. 9, Iss. 7, pp. 951-961
Open Access | Times Cited: 17
Susceptibility to innate immune activation in genetically-mediated myocarditis
Daniel Selgrade, Dominic E. Fullenkamp, Ivana A. Chychula, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 13
Open Access | Times Cited: 6
Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
Richard Carrick, Anneline S.J.M. te Riele, Alessio Gasperetti, et al.
Circulation Arrhythmia and Electrophysiology (2022) Vol. 15, Iss. 11
Open Access | Times Cited: 24
Pathophysiological Gaps, Diagnostic Challenges, and Uncertainties in Cardiac Sarcoidosis
Laura Ueberham, Andreas Hagendorff, Karin Klingel, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 6
Open Access | Times Cited: 14
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies
Giovanni Peretto, Giacomo De Luca, Andrea Villatore, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 7, pp. 755-765
Open Access | Times Cited: 13
Predicting ventricular tachycardia circuits in patients with arrhythmogenic right ventricular cardiomyopathy using genotype-specific heart digital twins
Yingnan Zhang, Kelly Zhang, Adityo Prakosa, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 13
PANoptosis is a prominent feature of desmoplakin cardiomyopathy
Melis Olcum, Leila Rouhi, Siyang Fan, et al.
The Journal of Cardiovascular Aging (2022) Vol. 3, Iss. 1, pp. 3-3
Open Access | Times Cited: 21
Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
Hamza El Hadi, Anne Freund, Steffen Desch, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 524-524
Open Access | Times Cited: 11
Hyperactivation of ATF4/TGF-β1 signaling contributes to the progressive cardiac fibrosis in Arrhythmogenic cardiomyopathy caused by DSG2 Variant
Baowei Zhang, Yizhang Wu, Chunjiang Zhou, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Desmoplakin Cardiomyopathy: Role of Inflammation and Potential Role of Disease-Modifying Therapies
Alessio Gasperetti, Richard Carrick, Steven A. Muller, et al.
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies
Giulia Bassetto, Federico Angriman, Carola Pio Loco Detto Gava, et al.
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top